The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism
The purpose of this study is to clarify the drug interaction profile of aumolertinib, and the influence of CYP3A4 genetic polymorphism on aumolertinib metabolic characteristics. Through microsomal enzyme reactions, we screened 153 drugs and identified 15 that significantly inhibited the metabolism o...
Saved in:
Main Authors: | Feng Ye (Author), Jinhuan Ni (Author), Xinyue Li (Author), Jing Wang (Author), Jianchao Luo (Author), Shiyu Wang (Author), Xiaoyu Xu (Author), Yunshan Zhong (Author), Jianchang Qian (Author), Zhongxiang Xiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine
by: Zhize Ye, et al.
Published: (2022) -
The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism
by: Nanyong Gao, et al.
Published: (2022) -
Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions
by: Qihui Kong, et al.
Published: (2023) -
Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism
by: Vera Dias, et al.
Published: (2011) -
New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases
by: Jian Lu, et al.
Published: (2020)